Home LiteratureArticle Details
PMID: 11602754 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Structural and functional analysis of interhelical interactions in the human immunodeficiency virus type 1 gp41 envelope glycoprotein by alanine-scanning mutagenesis.

Journal of virology ·Vol. 75 ·No. 22 ·2001-11-00 ·Pages 11146-56

Lu M, Stoller MO, Wang S, Liu J, Fagan MB, Nunberg JH

Abstract

Membrane fusion by human immunodeficiency virus type 1 (HIV-1) is promoted by the refolding of the viral envelope glycoprotein into a fusion-active conformation. The structure of the gp41 ectodomain core in its fusion-active state is a trimer of hairpins in which three antiparallel carboxyl-terminal helices pack into hydrophobic grooves on the surface of an amino-terminal trimeric coiled coil. In an effort to identify amino acid residues in these grooves that are critical for gp41 activation, we have used alanine-scanning mutagenesis to investigate the importance of individual side chains in determining the biophysical properties of the gp41 core and the membrane fusion activity of the gp120-gp41 complex. Alanine substitutions at Leu-556, Leu-565, Val-570, Gly-572, and Arg-579 positions severely impaired membrane fusion activity in envelope glycoproteins that were for the most part normally expressed. Whereas alanine mutations at Leu-565 and Val-570 destabilized the trimer-of-hairpins structure, mutations at Gly-572 and Arg-579 led to the formation of a stable gp41 core. Our results suggest that the Leu-565 and Val-570 residues are important determinants of conserved packing interactions between the amino- and carboxyl-terminal helices of gp41. We propose that the high degree of sequence conservation at Gly-572 and Arg-579 may result from selective pressures imposed by prefusogenic conformations of the HIV-1 envelope glycoprotein. Further analysis of the gp41 activation process may elucidate targets for antiviral intervention.

MeSH Terms
Alanine Amino Acid Sequence Animals COS Cells Cell Fusion Crystallization HIV Envelope Protein gp41/chemistry,physiology HIV-1/chemistry Molecular Sequence Data Mutagenesis Protein Conformation
Chemicals
HIV Envelope Protein gp41 Alanine
Authors & Affiliations
6 authors, click to expand affiliations / ORCID
Lu M
Department of Biochemistry, Weill Medical College of Cornell University, New York, New York 10021, USA. mlu@med.cornell.edu
Stoller M O
Wang S
Liu J
Fagan M B
Nunberg J H
References (67)
67 references, click to expand
  1. Subdomain folding and biological activity of the core structure from human immunodeficiency virus type 1 gp41: implications for viral membrane fusion.
    J Virol. 1999 May;73(5):4433-8 PMID: 10196341
  2. Trimerization specificity in HIV-1 gp41: analysis with a GCN4 leucine zipper model.
    Biochemistry. 1999 Apr 27;38(17):5378-85 PMID: 10220324
  3. Chemokine receptors as HIV-1 coreceptors: roles in viral entry, tropism, and disease.
    Annu Rev Immunol. 1999;17:657-700 PMID: 10358771
  4. Inhibition of human immunodeficiency virus type 1 infectivity by the gp41 core: role of a conserved hydrophobic cavity in membrane fusion.
    J Virol. 1999 Oct;73(10):8578-86 PMID: 10482611
  5. Selection of gp41-mediated HIV-1 cell entry inhibitors from biased combinatorial libraries of non-natural binding elements.
    Nat Struct Biol. 1999 Oct;6(10):953-60 PMID: 10504731
  6. Inhibiting HIV-1 entry: discovery of D-peptide inhibitors that target the gp41 coiled-coil pocket.
    Cell. 1999 Oct 1;99(1):103-15 PMID: 10520998
  7. HIV-1 entry inhibitors in the side pocket.
    Cell. 1999 Oct 29;99(3):243-6 PMID: 10555140
  8. A recombinant human immunodeficiency virus type 1 envelope glycoprotein complex stabilized by an intermolecular disulfide bond between the gp120 and gp41 subunits is an antigenic mimic of the trimeric virion-associated structure.
    J Virol. 2000 Jan;74(2):627-43 PMID: 10623724
  9. Buried polar interactions and conformational stability in the simian immunodeficiency virus (SIV) gp41 core.
    Biochemistry. 2000 Feb 1;39(4):676-85 PMID: 10651632
  10. Helical interactions in the HIV-1 gp41 core reveal structural basis for the inhibitory activity of gp41 peptides.
    Biochemistry. 2000 Feb 22;39(7):1634-42 PMID: 10677212
  11. Structure-function studies of the self-assembly domain of the human immunodeficiency virus type 1 transmembrane protein gp41.
    J Virol. 2000 Jun;74(11):5368-72 PMID: 10799616
  12. Antibody binding and neutralization of primary and T-cell line-adapted isolates of human immunodeficiency virus type 1.
    J Virol. 2001 Mar;75(6):2741-52 PMID: 11222697
  13. Protein design of an HIV-1 entry inhibitor.
    Science. 2001 Feb 2;291(5505):884-8 PMID: 11229405
  14. Thermodynamics of trimer-of-hairpins formation by the SIV gp41 envelope protein.
    J Mol Biol. 2001 Mar 23;307(2):637-56 PMID: 11254387
  15. Structural and functional analysis of the HIV gp41 core containing an Ile573 to Thr substitution: implications for membrane fusion.
    Biochemistry. 2001 Mar 6;40(9):2797-807 PMID: 11258890
  16. The CCP4 suite: programs for protein crystallography.
    Acta Crystallogr D Biol Crystallogr. 1994 Sep 1;50(Pt 5):760-3 PMID: 15299374
  17. Mutations in the leucine zipper of the human immunodeficiency virus type 1 transmembrane glycoprotein affect fusion and infectivity.
    J Virol. 1992 Aug;66(8):4748-56 PMID: 1629954
  18. Protein folding and association: insights from the interfacial and thermodynamic properties of hydrocarbons.
    Proteins. 1991;11(4):281-96 PMID: 1758883
  19. Differential loss of envelope glycoprotein gp120 from virions of human immunodeficiency virus type 1 isolates: effects on infectivity and neutralization.
    J Virol. 1991 Feb;65(2):852-60 PMID: 1898972
  20. Improved methods for building protein models in electron density maps and the location of errors in these models.
    Acta Crystallogr A. 1991 Mar 1;47 ( Pt 2):110-9 PMID: 2025413
  21. Heptad repeat sequences are located adjacent to hydrophobic regions in several types of virus fusion glycoproteins.
    J Gen Virol. 1990 Dec;71 ( Pt 12):3075-80 PMID: 2177097
  22. Use of T7 RNA polymerase to direct expression of cloned genes.
    Methods Enzymol. 1990;185:60-89 PMID: 2199796
  23. Retroviral envelope glycoproteins contain a "leucine zipper"-like repeat.
    AIDS Res Hum Retroviruses. 1990 Jun;6(6):703-6 PMID: 2364015
  24. High-resolution epitope mapping of hGH-receptor interactions by alanine-scanning mutagenesis.
    Science. 1989 Jun 2;244(4908):1081-5 PMID: 2471267
  25. Mutational analysis of the cleavage sequence of the human immunodeficiency virus type 1 envelope glycoprotein precursor gp160.
    J Virol. 1989 Nov;63(11):4670-5 PMID: 2677400
  26. Processing of X-ray diffraction data collected in oscillation mode.
    Methods Enzymol. 1997;276:307-26 PMID: 27754618
  27. A general model for the transmembrane proteins of HIV and other retroviruses.
    AIDS Res Hum Retroviruses. 1989 Aug;5(4):431-40 PMID: 2788443
  28. Polarized apical distribution of glycosyl-phosphatidylinositol-anchored proteins in a renal epithelial cell line.
    Proc Natl Acad Sci U S A. 1988 Dec;85(24):9557-61 PMID: 2974157
  29. Role of the HTLV-III/LAV envelope in syncytium formation and cytopathicity.
    Nature. 1986 Jul 31-Aug 6;322(6078):470-4 PMID: 3016552
  30. Rapid and efficient site-specific mutagenesis without phenotypic selection.
    Methods Enzymol. 1987;154:367-82 PMID: 3323813
  31. Determination of the helix and beta form of proteins in aqueous solution by circular dichroism.
    Biochemistry. 1974 Jul 30;13(16):3350-9 PMID: 4366945
  32. Spectroscopic determination of tryptophan and tyrosine in proteins.
    Biochemistry. 1967 Jul;6(7):1948-54 PMID: 6049437
  33. Analysis of data from the analytical ultracentrifuge by nonlinear least-squares techniques.
    Biophys J. 1981 Dec;36(3):575-88 PMID: 7326325
  34. Structure of the haemagglutinin membrane glycoprotein of influenza virus at 3 A resolution.
    Nature. 1981 Jan 29;289(5796):366-73 PMID: 7464906
  35. A molecular clasp in the human immunodeficiency virus (HIV) type 1 TM protein determines the anti-HIV activity of gp41 derivatives: implication for viral fusion.
    J Virol. 1995 Jun;69(6):3771-7 PMID: 7538176
  36. The inhibitory activity of an HIV type 1 peptide correlates with its ability to interact with a leucine zipper structure.
    AIDS Res Hum Retroviruses. 1995 Mar;11(3):323-5 PMID: 7786578
  37. Peptides corresponding to a predictive alpha-helical domain of human immunodeficiency virus type 1 gp41 are potent inhibitors of virus infection.
    Proc Natl Acad Sci U S A. 1994 Oct 11;91(21):9770-4 PMID: 7937889
  38. Epitope mapping and topology of baculovirus-expressed HIV-1 gp160 determined with a panel of murine monoclonal antibodies.
    AIDS Res Hum Retroviruses. 1994 Apr;10(4):371-81 PMID: 8068416
  39. Structure of influenza haemagglutinin at the pH of membrane fusion.
    Nature. 1994 Sep 1;371(6492):37-43 PMID: 8072525
  40. Crystal structure of an isoleucine-zipper trimer.
    Nature. 1994 Sep 1;371(6492):80-3 PMID: 8072533
  41. SETOR: hardware-lighted three-dimensional solid model representations of macromolecules.
    J Mol Graph. 1993 Jun;11(2):134-8, 127-8 PMID: 8347566
  42. HIV-1 inhibition by a peptide.
    Nature. 1993 Sep 9;365(6442):113 PMID: 8371754
  43. Effects of amino acid changes in the extracellular domain of the human immunodeficiency virus type 1 gp41 envelope glycoprotein.
    J Virol. 1993 May;67(5):2747-55 PMID: 8474172
  44. Mutational analysis of the leucine zipper-like motif of the human immunodeficiency virus type 1 envelope transmembrane glycoprotein.
    J Virol. 1993 Jun;67(6):3615-9 PMID: 8497069
  45. A spring-loaded mechanism for the conformational change of influenza hemagglutinin.
    Cell. 1993 May 21;73(4):823-32 PMID: 8500173
  46. Molecular cloning and analysis of functional envelope genes from human immunodeficiency virus type 1 sequence subtypes A through G. The WHO and NIAID Networks for HIV Isolation and Characterization.
    J Virol. 1996 Mar;70(3):1651-67 PMID: 8627686
  47. A trimeric structural domain of the HIV-1 transmembrane glycoprotein.
    Nat Struct Biol. 1995 Dec;2(12):1075-82 PMID: 8846219
  48. Core structure of gp41 from the HIV envelope glycoprotein.
    Cell. 1997 Apr 18;89(2):263-73 PMID: 9108481
  49. Atomic structure of the ectodomain from HIV-1 gp41.
    Nature. 1997 May 22;387(6631):426-30 PMID: 9163431
  50. Envelope glycoproteins from human immunodeficiency virus types 1 and 2 and simian immunodeficiency virus can use human CCR5 as a coreceptor for viral entry and make direct CD4-dependent interactions with this chemokine receptor.
    J Virol. 1997 Sep;71(9):6296-304 PMID: 9261346
  51. Enveloped viruses: a common mode of membrane fusion?.
    Curr Biol. 1997 Sep 1;7(9):R565-9 PMID: 9285698
  52. Atomic structure of a thermostable subdomain of HIV-1 gp41.
    Proc Natl Acad Sci U S A. 1997 Nov 11;94(23):12303-8 PMID: 9356444
  53. Conformational changes in cell surface HIV-1 envelope glycoproteins are triggered by cooperation between cell surface CD4 and co-receptors.
    J Biol Chem. 1998 Jan 2;273(1):404-9 PMID: 9417096
  54. A trimeric structural subdomain of the HIV-1 transmembrane glycoprotein.
    J Biomol Struct Dyn. 1997 Dec;15(3):465-71 PMID: 9439994
  55. Dilation of the human immunodeficiency virus-1 envelope glycoprotein fusion pore revealed by the inhibitory action of a synthetic peptide from gp41.
    J Cell Biol. 1998 Jan 26;140(2):315-23 PMID: 9442107
  56. Determinants of human immunodeficiency virus type 1 resistance to gp41-derived inhibitory peptides.
    J Virol. 1998 Feb;72(2):986-93 PMID: 9444991
  57. Coreceptor utilization by human immunodeficiency virus type 1 is not a primary determinant of neutralization sensitivity.
    J Virol. 1998 Mar;72(3):2491-5 PMID: 9499111
  58. Capture of an early fusion-active conformation of HIV-1 gp41.
    Nat Struct Biol. 1998 Apr;5(4):276-9 PMID: 9546217
  59. HIV entry and its inhibition.
    Cell. 1998 May 29;93(5):681-4 PMID: 9630213
  60. The HIV-1 envelope glycoproteins: fusogens, antigens, and immunogens.
    Science. 1998 Jun 19;280(5371):1884-8 PMID: 9632381
  61. Crystal structure of the simian immunodeficiency virus (SIV) gp41 core: conserved helical interactions underlie the broad inhibitory activity of gp41 peptides.
    Proc Natl Acad Sci U S A. 1998 Aug 4;95(16):9134-9 PMID: 9689046
  62. Crystallography & NMR system: A new software suite for macromolecular structure determination.
    Acta Crystallogr D Biol Crystallogr. 1998 Sep 1;54(Pt 5):905-21 PMID: 9757107
  63. Potent suppression of HIV-1 replication in humans by T-20, a peptide inhibitor of gp41-mediated virus entry.
    Nat Med. 1998 Nov;4(11):1302-7 PMID: 9809555
  64. Mutational analysis of residues in the coiled-coil domain of human immunodeficiency virus type 1 transmembrane protein gp41.
    J Virol. 1998 Dec;72(12):9676-82 PMID: 9811701
  65. A conformation-specific monoclonal antibody reacting with fusion-active gp41 from the human immunodeficiency virus type 1 envelope glycoprotein.
    J Virol. 1998 Dec;72(12):10213-7 PMID: 9811763
  66. Evidence that a prominent cavity in the coiled coil of HIV type 1 gp41 is an attractive drug target.
    Proc Natl Acad Sci U S A. 1998 Dec 22;95(26):15613-7 PMID: 9861018
  67. Coiled coils in both intracellular vesicle and viral membrane fusion.
    Cell. 1998 Dec 23;95(7):871-4 PMID: 9875840
Article Info
Journal
Journal of virology
Abbr.
J Virol
ISSN
0022-538X
Published
2001-11-00
Pages
11146-56
Language
English
Region
United States
NLM ID
0113724
PMCID
PMC114694
Subset
IM
Grants
NIAID NIH HHS · AI44669 · United States
NIAID NIH HHS · AI48385 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com